WallStSmart

Acme United Corporation (ACU)vsColgate-Palmolive Company (CL)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 9551% more annual revenue ($21.28B vs $220.55M). CL leads profitability with a 9.7% profit margin vs 5.1%. ACU appears more attractively valued with a PEG of 1.54. ACU earns a higher WallStSmart Score of 57/100 (C).

ACU

Buy

57

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.0Quality: 8.5
Piotroski: 5/9Altman Z: 3.97

CL

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACUSignificantly Overvalued (-23.4%)

Margin of Safety

-23.4%

Fair Value

$35.49

Current Price

$69.50

$34.01 premium

UndervaluedFair: $35.49Overvalued
CLUndervalued (+5.0%)

Margin of Safety

+5.0%

Fair Value

$100.26

Current Price

$97.43

$2.83 discount

UndervaluedFair: $100.26Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACU4 strengths · Avg: 9.0/10
EPS GrowthGrowth
73.9%10/10

Earnings expanding 73.9% YoY

Altman Z-ScoreHealth
3.9710/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
18.2%8/10

18.2% revenue growth

CL3 strengths · Avg: 9.7/10
Return on EquityProfitability
863.1%10/10

Every $100 of equity generates 863 in profit

Altman Z-ScoreHealth
4.4010/10

Safe zone — low bankruptcy risk

Market CapQuality
$75.75B9/10

Large-cap with strong market position

Areas to Watch

ACU4 concerns · Avg: 3.3/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Market CapQuality
$257.86M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

Operating MarginProfitability
3.9%3/10

Operating margin of 3.9%

CL4 concerns · Avg: 4.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

P/E RatioValuation
37.1x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.6%4/10

4.6% revenue growth

EPS GrowthGrowth
3.3%4/10

3.3% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : ACU

The strongest argument for ACU centers on EPS Growth, Altman Z-Score, Price/Book. Revenue growth of 18.2% demonstrates continued momentum.

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bear Case : ACU

The primary concerns for ACU are PEG Ratio, Market Cap, Profit Margin.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Revenue Growth. Debt-to-equity of 33.29 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACU profiles as a growth stock while CL is a value play — different risk/reward profiles.

ACU carries more volatility with a beta of 0.41 — expect wider price swings.

ACU is growing revenue faster at 18.2% — sustainability is the question.

CL generates stronger free cash flow (867M), providing more financial flexibility.

Bottom Line

ACU scores higher overall (57/100 vs 54/100) and 18.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acme United Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Acme United Corporation supplies cutting, measuring, first aid, sharpening and safety products for the school, home, office, hardware, sporting goods and industrial markets in the United States, Canada, Europe and Asia. The company is headquartered in Shelton, Connecticut.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Want to dig deeper into these stocks?